Analysis of Unused and Expired Medication Collected through Home Pharmaceutical Care Service

Yakhak Hoeji ◽  
2021 ◽  
Vol 65 (6) ◽  
pp. 413-423
Author(s):  
Jiwon Hwang ◽  
Minkyung Lee ◽  
Yonghoon Seo ◽  
Kwang Joon Kim
Keyword(s):  
Pharmaceutical Care ◽  
Care Service ◽  
Pharmaceutical Care Service

scholarly journals Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service

2011 ◽  
Vol 55 (9) ◽  
pp. 686-691 ◽  
Author(s):  
Anna Paula de Sá Borges ◽  
Camilo Molino Guidoni ◽  
Osvaldo de Freitas ◽  
Leonardo Régis Leira Pereira
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Pharmaceutical Care ◽  
Care Service ◽  
Emergency Department Visits ◽  
Care Group ◽  
Control Group ◽  
Pharmaceutical Care Service

OBJECTIVE: To analyze the costs related to visits and drug prescription in outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. SUBJECTS AND METHODS: A prospective and experimental study was carried out. Seventy one patients were divided into two groups: control and pharmaceutical care. Patients in the pharmaceutical care group were followed up monthly by a single clinical pharmacist. RESULTS: The pharmaceutical care group had a statistically significant reduction in costs of metformin and emergency department visits, and increased costs with their family physicians. On the other hand, the control group had a statistically significant increase of 21.3% in the general costs of treatment and visits. CONCLUSION: The pharmaceutical care group maintained the same costs related to drugs and visits, while the control group showed a significant increase in general costs.

Medication Regimen Complexity Index

2020 ◽  
Vol 35 (2) ◽  
pp. 50-51
Author(s):  
Wei Terk Chang
Keyword(s):  
Clinical Practice ◽  
Pharmaceutical Care ◽  
Care Service ◽  
Medication Therapy Management ◽  
Medication Regimen ◽  
Medication Therapy ◽  
Medication Regimen Complexity ◽  
Complexity Index ◽  
Regimen Complexity ◽  
Pharmaceutical Care Service

This complexity index could be used in clinical practice to more accurately target patients who would benefit from intensive pharmaceutical care service such as medication therapy management.

scholarly journals CLINICAL AND EPIDEMIOLOGICAL PROFILE OF ELDERLY PATIENTS WITH CHAGAS DISEASE FOLLOWED BETWEEN 2005-2013 BY PHARMACEUTICAL CARE SERVICE IN CEARÁ STATE, NORTHEASTERN BRAZIL

2015 ◽  
Vol 57 (2) ◽  
pp. 145-152 ◽  
Author(s):  
Laíse dos Santos PEREIRA ◽  
Erlane Chaves FREITAS ◽  
Arduína Sofia Ortet de Barros Vasconcelos FIDALGO ◽  
Mônica Coelho ANDRADE ◽  
Darlan da Silva CÂNDIDO ◽  
...  
Keyword(s):  
Pharmaceutical Care ◽  
Chagas Disease ◽  
Family Income ◽  
Care Service ◽  
The Elderly ◽  
University Hospital ◽  
Northeastern Brazil ◽  
Bundle Branch Block ◽  
Epidemiological Profile ◽  
Pharmaceutical Care Service

By controlling the transmission of Chagas disease, the challenge of providing assistance to millions of infected patients that reach old age arises. In this study, the socioeconomic, demographic and comorbidity records of all elderly chagasic patients followed at the Pharmaceutical Care Service of the Chagas Disease Research Laboratory were assessed. The information related to the clinical form of the disease was obtained from medical records provided by the Walter Cantídio University Hospital. The profile of the studied population was: women (50.5%); mean age of 67 years; retired (54.6%); married (51.6 %); high illiteracy rate (40.2%); and family income equal to the minimum wage (51.5%). The predominant clinical forms of Chagas disease were cardiac (65.3%) and indeterminate (14.7%). The main electrocardiographic changes were the right bundle branch block (41.0%), associated or not with the anterosuperior left bundle branch block (27.4%). The average number of comorbidities per patient was 2.23 ± 1.54, with systemic arterial hypertension being the main one found (67.0%). It was found that the elderly comprise a vulnerable group of patients that associate aging with cardiac and/or digestive disorders resulting from the evolution of Chagas disease and other comorbidities, which requires special attention from health services to ensure more appropriate medical and social care.

scholarly journals Drug-related problems observed in a pharmaceutical care service, Belo Horizonte, Brazil

2009 ◽  
Vol 45 (2) ◽  
pp. 321-330 ◽  
Author(s):  
Yone de Almeida Nascimento ◽  
Wânia da Silva Carvalho ◽  
Francisco de Assis Acurcio
Keyword(s):  
Pharmaceutical Care ◽  
Care Service ◽  
Health Problems ◽  
Drug Related Problems ◽  
University Center ◽  
Female Sex ◽  
Concurrent Study ◽  
Belo Horizonte ◽  
Pharmaceutical Care Service

This present observational, longitudinal, and non-concurrent study was developed with the purposes of evaluate the profile of patients attended by a pharmacotherapeutic follow-up service and describe the Drug-Related Problems (DRPs) found over there; determine the proportion of DRPs between the health problems presented by the studied population, classifying them and identifying the situations related with their appearance. The study was developed at the School Pharmacy of Newton Paiva University Center, Belo Horizonte, MG, during the period from 2001 November up to 2003 November. Ninety seven patients have been evaluated, the majority of female sex (66.0%), with up to 8 years of scholarship (45.4%), mean age of 56.7 ± 13.0 years; mean of 4 ± 2 diagnosed diseases; 7 ± 6 complaints and 4 ± 2 medications per patient. Nine hundred and twelve health problems have been identified: 56.5% uncontrolled. From the uncontrolled problems, 380 (73.6%) were DRPs and between these, 81 (21.3%) were risks for DRP. From the 97 followed-up patients, 89 (91.7%) have presented at least one DRP during the follow-up. The more frequent DRPs were related to effectiveness (53.2%), to necessity (25.2%) and to safety (21.6%). A great number of uncontrolled problems was observed, as well as the possibility to resolve them by means of pharmaceutical care, indicating so the resolutive potential of this practice.

scholarly journals Advancing Pharmacy Service using Big Data – Are We Fully Utilising the Big Data’s Potential Yet?

2018 ◽  
Vol 21 ◽  
pp. 217-221 ◽  
Author(s):  
Hui-Qi See ◽  
Jin-Ning Chan ◽  
Shu-Jin Ling ◽  
Shang-Cheng Gan ◽  
Chee-Onn Leong ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Big Data ◽  
Medication Error ◽  
Precision Medicine ◽  
Pharmaceutical Care ◽  
Clinical Pharmacy ◽  
Care Service ◽  
Healthcare Industry ◽  
Future Direction ◽  
Pharmaceutical Care Service

Big data is anticipated to have large implications in clinical pharmacy, in view of its potential in enhancing precision medicine and to avoid medication error. However, it is equally debatable since such a powerful tool may also disrupt the need of pharmacist in healthcare industry. In this article, we commented the contribution of Big Data in various aspects of clinical pharmacy including advancing pharmaceutical care service, optimising drug supplies, managing clinical trials, and strengthening pharmacovigilance. The future direction of the usage of Big Data related to clinical pharmacy will be discussed. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.

Implementation of a pharmaceutical care service: prescriptionists’, pharmacists’ and doctors’ views

2007 ◽  
Vol 29 (6) ◽  
pp. 593-602 ◽  
Author(s):  
Anna T. Montgomery ◽  
Sofia Kälvemark-Sporrong ◽  
Mari Henning ◽  
Mary P. Tully ◽  
Åsa Kettis-Lindblad
Keyword(s):  
Pharmaceutical Care ◽  
Care Service ◽  
Pharmaceutical Care Service
Sign in / Sign up

Export Citation Format

Share Document